Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
Bilcare Limited

Bilcare Limited

NSE: BI
Containers/PackagingProcess IndustriesSMALL CAPMCap ₹213.5 Cr
₹90.66₹-1.85 (-2.00%)

Market Closed • NSE

Market cap₹213.5 Cr
Enterprise value₹710.3 Cr
P/E TTM27.56
P/B1.08
EPS TTM₹3.29
ROCE7.06%
D/E8.37
Dividend yield0.00%
Face value₹10.00
52W high₹113.00
52W low₹85.00
Price chart(1Y)
1Y Return:+46.23% (+₹28.66)
H: ₹113L: ₹55
1W-2.53%
1M-11.55%
3M+46.18%
Today at a glance

Day range

₹90.66₹92.00

52 week range

₹85.00₹113.00
Volume7.6K0.44x 20D avg
Free float50.00%-55.90% volume

Bilcare Limited closed at INR90.66 (-2%) on volume 0.44x its 20-day average, trading 19.77% below its 52-week high.

Technical analysis
RSI (14)44.3Neutral (30–70)
MACDBEARISHBearish (Below signal)
ATR (14)₹3.26High
SMA 20₹97.86BEARISH
SMA 50₹90.19BULLISH
SMA 100₹75.90BULLISH
SMA 200—N/A
CPR bottom₹92.03
Pivot₹92.19
CPR top₹92.35
What changed recently?

2026-Q2

Q2 FY2026 Financial Results

PAT moved +87.5% QoQ

Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
FAIL3/4 criteria
Non-Compliant (Financial Ratios)
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio₹620.0 Cr₹213.5 Cr290.45%≤ 33%FAIL
Non-halal income ratio–₹734.0 Cr0.00%≤ 5%PASS
Illiquid assets ratio–₹843.0 Cr—≥ 20%PASS
Receivables ratio–₹843.0 Cr—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E27.5620.80
Forward P/E——
P/B1.081.30
EV/EBITDA15.8018.00
PEG—1.50
Earnings yield3.604.80
Growth & profitability
RevenuePAT
FY21PAT margin -1.80%
FY22PAT margin -0.50%
FY23PAT margin 5.10%
FY24PAT margin -7.90%
FY25PAT margin -3.60%
FY26PAT margin -2.30%

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y-9.20%
Revenue CAGR 5Y+3.30%
PAT CAGR 3Y—
PAT CAGR 5Y—
Operating margin14.57%
Net margin1.45%
Financial health & cash flow
Net debt₹620.0 CrModerate
Interest coverage0.60xEBIT / interest
CFO / PAT—x3Y average
Net debt / EBITDA13.78xLeverage
Operating cash flow₹128.0 Cr
Capital expenditure–
Free cash flow₹128.0 Cr
Financial statements

Complete reported financial history · Values use the company's reporting currency

Hover over the chart for exact reported values. Percentage lines use the right-hand axis.

Fundamental scorecard
Overall40/100
Valuation60/100
Profitability50/100
Financial health10/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Established operational history in the sector

Active institutional participation

Risks

Elevated Leverage Burden: Debt-to-Equity stands at 8.37x

Tight Debt Servicing: Interest coverage ratio is under 2.0x

Bull case

Market Leadership: Established operational scale in Containers/Packaging.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Shareholding pattern
Quarterly ownership historyLatest valid period · December 2025

Ownership distribution

Dec 2025Latest holding

Category trends

Hover over a period for exact holdings

70%47%23%0%Sept 2024Dec 2024Jun 2025Sept 2025Dec 2025
0.04%Institutional holding
69.95%Public holding
5Periods available
0.00%Promoter pledged
15.82KShareholders
Peer comparison

Compare valuation, latest quarterly performance and year-on-year growth

8 companies
Company nameMarket cap ₹ CrP/E ratioDividend yield %Quarterly sales ₹ CrProfit after tax ₹ CrSales growth %Profit growth %
KAMA Holdings Limited
KAMA Holdings LimitedKAMAHOLD
Open analysis
₹7,245.416.630.00%————
Kothari Industrial Corporation Limited
Kothari Industrial Corporation LimitedKOTIC
Open analysis
₹1,604.45—0.00%₹52.00-₹29.00+33.33%-1,350.00%
3B Blackbio Dx Limited
3B Blackbio Dx Limited3BBLACKBIO
Open analysis
₹1,241.4021.980.34%₹33.49₹8.98+50.65%-29.01%
Bajaj Steel Industries Limited
Bajaj Steel Industries LimitedBAJAJST
Open analysis
₹628.2122.8531.00%₹120.35-₹0.27+11.92%-103.65%
Sharat Industries Limited
Sharat Industries LimitedSHINDL
Open analysis
₹608.5336.170.00%₹120.30₹6.28+4.43%+16.95%
ACS Technologies Limited
ACS Technologies LimitedACSTECH
Open analysis
₹492.7434.140.00%₹95.12₹3.92+244.26%+378.05%
Shree Ajit Pulp and Paper Limited
Shree Ajit Pulp and Paper LimitedSAPPL
Open analysis
₹288.616.950.00%₹201.00₹19.00+13.56%+171.43%
Bilcare Limited
Bilcare LimitedBI
Current stock
₹213.4627.560.00%₹226.00₹15.00+21.51%+250.00%
About Bilcare Limited
Bilcare Limited

Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).

IndiaProcess Industries

Questions investors ask
Is Bilcare Limited Shariah compliant?

Bilcare Limited is currently screened as Non-Compliant (Financial Ratios) under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (290.45%) exceeds AAOIFI threshold (≤ 33%).

What is Bilcare Limited's current valuation relative to peers?

Bilcare Limited trades at a P/E of 27.6x compared to the sector median of 20.8x, and a Price-to-Book of 1.1x.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of 8.37x and a Net Debt to EBITDA ratio of 13.78x. Interest coverage is 0.6x.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at 3.3% while net profit growth averaged consistent levels.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.